Plasma Epstein-Barr virus DNA and risk of nasopharyngeal carcinoma in a prospective seropositive population

Plasma Epstein-Barr virus DNA and risk of nasopharyngeal carcinoma in a prospective seropositive population

Abstract Objective Plasma Epstein-Barr virus (EBV) DNA is considered a biomarker for nasopharyngeal carcinoma (NPC). However, its long-term role in NPC development is unclear. Materials and methods A total of 1363 participants seropositive for EBV VCA-IgA and EBNA1-IgA in a community-based NPC scree...

Full description

Bibliographic Details
Main Authors: Wen-Jie Chen, Wen-Na Xu, Hai-Yun Wang, Xiao-Xia Chen, Xue-Qi Li, Shang-Hang Xie, Dong-Feng Lin, Su-Mei Cao
Format: Article
Language:English
Published: BMC 2021-06-01
Series:BMC Cancer
Subjects:
Nasopharyngeal carcinoma
Plasma EBV DNA
Risk prediction
Population screening
Online Access:https://doi.org/10.1186/s12885-021-08408-0

Internet

https://doi.org/10.1186/s12885-021-08408-0

Similar Items